A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients

Rationale: Effective targeting therapies are limited in Hepatocellular carcinoma (HCC) clinic. Characterization of tumor suppressor genes (TSGs) and elucidation their signaling cascades could shed light on new strategies for developing targeting therapies for HCC. Methods: We checked genome-wide DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Feng, Zhou, Qian, Liu, Lu, Zeng, Guandi, Ci, Weimin, Liu, Wanting, Zhang, Gong, Zhang, Zhiyi, Wang, Peng, Zhang, Aiqun, Gao, Yunfei, Yu, Lei, He, Qingyu, Chen, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929984/
https://www.ncbi.nlm.nih.gov/pubmed/31903133
http://dx.doi.org/10.7150/thno.38060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929984/
https://www.ncbi.nlm.nih.gov/pubmed/31903133
http://dx.doi.org/10.7150/thno.38060

Ejemplares similares